Modern Diagnostic & Research C (BSE: 544673) is a Gurugram, Haryana-based company in the Medical Diagnostic Centres industry. With a market capitalisation of ₹88 Cr, it ranks #3,348 by market cap among the 6,197 Indian listed companies on FinBizNet, and #12 of 18 in Medical Diagnostic Centres. At ₹58.00 (as of 16 Nov 2026), the share price is 42.0% below its 52-week high of ₹100.00 and 28.9% above its 52-week low of ₹45.00.
| Current Price | ₹58.00 |
|---|---|
| Market Cap | ₹88 Cr |
| BSE Code | 544673 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Services > Medical Diagnostic Centres |
| P/E Ratio | 16.7 |
| Return on Assets | 5.64% |
| 52-Week Range | ₹45.00 – ₹100.00 |
| 3-Month Price Change | +16.0% |
| Beta (1Y) | 0.86 |
| Headquarters | Gurugram, Haryana |
| Website | www.mdrcindia.com |
Delivery averaged 92.1% of traded volume across 12 BSE sessions (21 Oct 2026 – 11 Nov 2026).
Modern Diagnostic & Research Centre Limited provides diagnostic and related healthcare tests services to individual patients, corporates, hospitals and other healthcare providers in India. It offers diagnostic tests, such as complete blood counts, liver and kidney function tests, lipid profiles, hormone analysis, autoimmune disease markers, cancer screening, and infectious disease testing; and radiology services magnetic resonance imaging, computerized tomography scan (CT) scans, PET-CT, ultrasound, color Doppler studies, digital X-rays, mammography, and interventional radiology, as well as heart lab, neuro lab and laboratory, electrocardiogram, cone beam CT, orthopantomogram, pulmonary function tests, etc. The company also provides pathology services, such as haematology, biochemistry, clinical pathology, serology, immunology, histopathology, cytopathology, microbiology, molecular diagnostics, and genetic testing. In addition, it offers value-added services, including home collection
1. Radiology-This segment offers non-invasive diagnostic techniques to check the functionality of vital body organs, such as heart, lungs, and brain. It includes EEG, CT scan, MRI Scan1, and ultrasound scan. 2. Pathology-This segment engages in testing blood, urine, or other body fluids to check for infections while use of medical imaging techniques to diagnose and treat diseases and injuries. 3. NA-NA 4. NA-NA
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Dr. Lal Pathlabs Ltd | ₹33,934 Cr | 66.4 | 21.48% | ₹874 Cr | +28.7% |
| Vijaya Diagnostic Centre Limited | ₹14,665 Cr | 84.3 | 19.70% | ₹255 Cr | +38.5% |
| Metropolis Healthcare Limited | ₹11,952 Cr | 61.5 | 13.37% | ₹497 Cr | +14.9% |
| Throcare Technologies Ltd | ₹7,764 Cr | 47.6 | 28.74% | ₹271 Cr | +7.5% |
| SURAKSHA DIAGNOSTIC LIMITED | ₹1,856 Cr | 55.4 | 13.84% | ₹99 Cr | +6.9% |
| Krsnaa Diagnostics Ltd | ₹1,625 Cr | 16.8 | 10.89% | ₹271 Cr | -27.0% |
| Gaudium IVF and Women Health Limited | ₹803 Cr | 27.4 | 16.08% | ₹37 Cr | — |
| Chandan Healthcare Limited | ₹582 Cr | 21.9 | 18.43% | ₹81 Cr | — |
| Modern Diagnostic & Research C | ₹88 Cr | 16.7 | — | — | — |
Listed by market capitalisation. Ratios are shown for context only.
Modern Diagnostic & Research C is trading at ₹58.00, with a market capitalisation of ₹88 Cr.
Modern Diagnostic & Research C operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Medical Diagnostic Centres).
Modern Diagnostic & Research C has a P/E of 16.7.
Modern Diagnostic & Research C is listed on the BSE under the scrip code 544673.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.